Genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) homologue from Bothrops pauloensis snake venom, on MDA-MB-231 breast cancer cells
Author
Butantan affiliation
External affiliation
Publication type
Article
Language
English
Access rights
Restricted access
Appears in Collections:
Metrics
Abstract
Herein we evaluated the genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) from Bothrops pauloensis, on breast cancer cells. BnSP-6 was able to induce a higher cytotoxic and genotoxic activity in MDA-MB-231 cells, when compared to MCF10A (a non-tumorigenic breast cell line), suggesting that this protein presented a possible preference for cancer cells. BnSP-6 inhibited MDA-MB-231 proliferation at 24, 48 and 72?h. In addition, BnSP-6 induced significant increase in the percentage of TUNEL-positive cells, a marker of DNA damage. To obtain novel insight into the direct DNA damage interference in MDA-MB-231 survival and proliferation, we evaluated cell cycle progression. BnSP-6 produced a significant decrease in 2N (G1) and an increase in the G2/M phase and this capacity is likely related to the modulation of expression of progression cell cycle-associated genes (CCND1, CCNE1, CDC25A, CHEK2, E2F1, CDH-1 and NF-kB). Taken together, these results indicate that BnSP-6 induces DNA damage in breast cancer cells and is an attractive model for developing innovative therapeutic agents against breast cancer.
Reference
Silva MFS., Lopes DS, Teixeira SC, Gimenes SNC, Azevedo FVPV, Polloni L, et al. Genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) homologue from Bothrops pauloensis snake venom, on MDA-MB-231 breast cancer cells. Int. J. Biol. Macromol.. 2018 Oct;118(part A):311-9. doi:10.1016/j.ijbiomac.2018.06.082.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/2529
URL
http://dx.doi.org/10.1016/j.ijbiomac.2018.06.082
Journal title
Keywords
Funding agency
Issue Date
2018
Show full item record
The access to the publications deposited in this repository respects the licenses from journals and publishers.